VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Rigel Pharmaceuticals, Inc. (RIGL) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $904M · P/E 3.0 · revenue $277M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows